Why Exercise Matters When You're on a Weight Loss Drug

By George Green · February 24, 2026 · 4 min read

Woman walking outdoors, representing gentle exercise alongside GLP-1 weight loss medication.

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have changed the game. Clinical trials have shown weight loss of 15-21% of body weight, results previously only seen with bariatric surgery. If you're taking one, you're probably already seeing real changes.

But there's a catch most people don't hear about until later: what you lose matters just as much as how much you lose.


The muscle problem nobody talks about

When your body loses weight, from any cause, whether dieting, surgery, or medication, it doesn't shed fat and nothing else. It also loses some lean mass, including muscle.

Research published in Circulation by the American Heart Association found that muscle changes with GLP-1 medications appear to be broadly proportionate to total weight lost. A large genetic analysis of over 800,000 individuals confirmed that while both fat and muscle decrease during treatment, fat loss is much greater, so overall body composition does improve. But the muscle loss is real, and for many people it's meaningful.

The risk is highest in the first 3-6 months, when weight loss is most rapid. According to a 2025 review in ScienceDirect, that's when lean body mass reduction tends to peak, and then levels off if you're eating enough protein and staying active.

UC Davis exercise physiologist Keith Baar puts it plainly: "It is still important for patients taking GLP-1 medication to limit muscle wasting through exercise and high-quality protein."


Why muscle loss matters, especially as you get older

Muscle isn't just about looking toned. It's metabolically active tissue that does critical work:

  • It keeps your metabolism running. Skeletal muscle is one of the primary drivers of your resting metabolic rate. Lose it, and your body burns fewer calories at rest, which makes long-term weight maintenance harder.
  • It's where glucose goes. Muscle is the body's primary site for blood sugar disposal. Less muscle means less efficient glucose metabolism, which matters particularly for people using GLP-1s to manage diabetes or insulin resistance.
  • It keeps you functional. Strength, balance, bone density, and the ability to do everyday things without getting hurt all depend heavily on maintaining muscle mass.

For women over 40, this is even more pressing. After 40, we naturally lose 3-8% of muscle mass per decade even without weight loss interventions. GLP-1 therapy on top of that, without exercise to counteract it, accelerates a process that was already underway.


What the research actually recommends

The good news: exercise works. A combination of movement and adequate protein intake has been shown in multiple studies to protect against muscle loss during GLP-1 therapy.

A study published in the New England Journal of Medicine (Lundgren et al., 2021) found that combining exercise with GLP-1 treatment led to better long-term weight maintenance than either approach alone. The benefits persisted even after treatment stopped, in participants who kept exercising.

Researchers at Mass General Brigham found that "patients who engage in regular exercise at initiation and throughout their treatment have the best chances of preserving lean body mass and maintaining loss of fat mass."

The European Association for the Study of Obesity's Physical Activity Working Group recommends resistance training specifically for preserving lean mass during weight loss. But the research also shows that aerobic exercise, including walking, helps maintain cardiovascular fitness, muscle function, and metabolic health throughout treatment.

You don't need to run marathons or lift heavy weights. Consistent, moderate movement, especially if you're starting from a low baseline, makes a real difference.


But getting started is hard

Here's what nobody says loudly enough: GLP-1 medications often make the first weeks of exercise harder, not easier.

Nausea, fatigue, and reduced appetite are common side effects, particularly early in treatment. You're eating less, which means less fuel. Your body is changing rapidly. The last thing many people feel like doing is going for a walk.

And then there's the motivation problem. Most fitness apps and challenges assume you want to work hard and track progress against big goals. They're built for people who are already moving. When you're starting from scratch, or restarting after a long break, the gap between where you are and where those apps expect you to be can feel enormous.

That discouragement is one of the main reasons people don't exercise consistently on GLP-1 therapy, even when they know they should.


Why Motion is built for exactly this moment

Motion was designed for people who want to build a sustainable movement habit, not people trying to win a race.

Smart goals that start where you are. Motion's AI adapts your daily target based on your actual activity, not an arbitrary number. If you manage a 10-minute walk today, that counts. Tomorrow's goal adjusts to meet you where you are. There's no "falling behind."

Effort-based challenges, not raw numbers. Motion's Activity Battles measure effort percentage rather than step counts. That means someone walking 2,000 steps and working hard is competing on equal terms with someone walking 8,000. When you're getting started, or on a rough week, you're not at the bottom of a leaderboard feeling like you've failed.

It keeps things fun. Motion's Motmots are virtual companions that grow alongside your activity. Fit Bingo challenges mix up your routine. Habit research consistently shows that enjoyment and novelty are two of the most reliable drivers of long-term exercise adherence. Making movement feel like play rather than medicine matters.

A community that gets it. Motion's users are mostly women 40+, many of them navigating exactly the same things: health changes, busy lives, the challenge of rebuilding fitness after time away. The community celebrates every kind of movement. Nobody's going to make you feel bad for a slow week.


The research is clear: GLP-1 medications work best when paired with regular activity. Exercise protects your muscle, supports your metabolism, and makes the results last. The challenge is finding a way to actually do it, especially when motivation is the hardest part.

That's what Motion is for.

Try Motion free →

Sources

  1. Linge J, Birkenfeld AL, Neeland IJ. Muscle mass and glucagon-like peptide-1 receptor agonists. Circulation. 2024;150:1288-98. doi:10.1161/CIRCULATIONAHA.124.067676
  2. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with GLP-1-based therapies. Diabetes, Obesity and Metabolism. 2024;26:16-27. doi:10.1111/dom.15728
  3. Lundgren JR, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021;384:1719-1730. doi:10.1056/NEJMoa2028198
  4. Frontiers in Clinical Diabetes and Healthcare. GLP-1 agonists and exercise. 2025. pmc.ncbi.nlm.nih.gov
  5. Mass General Brigham. Preserving lean body mass in patients taking GLP-1 for weight loss. 2025. advances.massgeneral.org
  6. UC Davis Health. Systemic impact of GLP-1-based therapies. December 2025. health.ucdavis.edu
  7. ACE Fitness. GLP-1s and Lean Mass: What the Research Shows. June 2025. acefitness.org
  8. ukactive. GLP-1 medications and muscle mass preservation. December 2025. ukactive.com

Frequently asked questions

If you have anything else you want to ask, reach out to us.

Motion app icon

Your Fitness Journey Starts Here

Download Motion free and discover why this is the fitness app you'll actually keep using. Your future self (and your Motmot) will thank you.

App StorePlay Store